-
Diagnostics World | Beginning today, the research team at Children’s Mercy Kansas City is bringing long read sequencing to clinical care, following three years of research and testing of PacBio HiFi sequencing. The transition is expected to speed the diagnostics odyssey for critically ill patients and their families.
Oct 6, 2023
-
Diagnostics World | Soon it may be possible for people to walk into their doctor’s office anywhere in the world and learn from a fingerprick blood sample if they are genetically predisposed to developing osteoporosis. It will matter not if those individuals are anywhere near the age of menopause, or if they’re male or female, because the SNPs being measured were present from the day they were born and men are by no means immune to the condition.
Oct 4, 2023
-
Diagnostics World | Over 900 genes have been implicated in the resistance of tumors to platinum-based chemotherapy that map to many different cellular pathways, thwarting efforts to identify a biomarker to predict refractoriness.
Oct 3, 2023
-
Diagnostics World | Paige and Microsoft aim to build the world’s largest image-based AI models for digital pathology and oncology; the GA4GH Board of Directors has elected Heidi Rehm to succeed Ewan Birney; The U.S. Department of Health and Human Services (HHS) announced new details of its agreement with Regeneron to extend its public-private partnership to develop life-saving monoclonal antibodies as part of Project NextGen enhancing our preparedness for COVID-19 strains and variants; and more.
Sep 28, 2023
-
Diagnostics World | Moderna and Immatics launch a strategic research and development collaboration to pioneer novel and transformative therapies for cancer patients with high unmet medical need; Generate:Biomedicines secures huge funding to advance its AI platform; Ibex Medical Analysis’ Galen platform transforms cancer diagnostics with AI; more.
Sep 27, 2023
-
Diagnostics World | Digital anatomic pathology allows for several potential benefits in clinical research, from speedier and traceable processes to improved consistency in visualisations and assessment outcomes.
Sep 22, 2023
-
Diagnostics World | Uncertainty surrounds the reimbursement landscape for multiplex testing and mandates and guidance issued as part of the COVID-19 public health emergency (PHE) only added a fresh dose of complications.
Sep 20, 2023
-
Diagnostics World | Researchers in the U.S. and Sweden have identified a biomarker (MTBR-tau243) for Alzheimer’s disease that tracks with the amount of damaging tau tangles in the brain and, when combined with a specific phosphorylated tau species (p-tau205), is nearly as predictive of cognitive function as tau-positron emission tomography (tau-PET) imaging.
Sep 19, 2023
-
Diagnostics World | Researchers from Johns Hopkins University and the Risk Management Foundation of the Harvard Medical Institutions have come up with a national estimate of serious harms from diagnostic error.
Sep 13, 2023
-
Diagnostics World | The recent discovery that the metastatic spread of breast cancer accelerates during sleep sparked a lively conversation at last month’s Next Generation Dx Summit about new paths of exploration for thwarting a deadly pan-cancer process claiming 12 lives worldwide every minute.
Sep 12, 2023
-
Diagnostics World | Researchers in the Czech Republic succeeded in using ChatGPT (Chat Generative Pre-trained Transformer) to produce a convincing scientific article in only one hour with no special human training—a feat intended to point out the current capabilities of large language models (LLMs).
Sep 7, 2023
-
Diagnostics World News | Illumina today announced that its Board of Directors has appointed Jacob Thaysen, Ph.D., senior vice president of Agilent Technologies and president of its Life Sciences and Applied Markets Group, as Illumina’s next Chief Executive Officer, effective September 25, 2023.
Sep 5, 2023
-
Diagnostics World | Medicare, the single largest payer for healthcare in the United States, has a hodgepodge of national and state policies capable of bankrupting innovation in molecular diagnostics. It is an inequitable, fiscally perplexing, needlessly verbose, and fraud-prone system but, if there’s a bright spot, it’s the Molecular Diagnostic Services Program (MolDX) responsible for technology assessments and claims disbursement for more than half the country.
Sep 5, 2023
-
Diagnostics World | Illumina and Pillar partner up to make Pillar’s oncology assays commercially available on a global scale; C2N Diagnostics releases the PrecivityAD2 blood test, a clinical care assay that meets the standard of care with currently available PET scans and cerebrospinal fluid tests; University of Missouri researchers developed an innovative method using nanopores; more.
Aug 31, 2023
-
Diagnostics World | ADARx Pharmaceuticals will use financing for treatment of a broad range of diseases; A-Alpha Bio plans to use Series A2 funding to accelerate antibody discovery and development for emerging biothreats, including HIV; Cytomos will scale-up market testing of its technology platform for cell analysis; more.
Aug 30, 2023
-
Diagnostics World | The U.S. Food and Drug Administration (FDA) has been making moves signaling its intention to better align the regulatory framework for companion diagnostics (CDx) to what is happening in real-world clinical practice.
Aug 24, 2023
-
Diagnostics World | Public health agencies have grappled with a succession of data problems associated with the COVID-19 pandemic, most notably how to accurately track prevalence rates when people are self-testing in the privacy of their home and don’t necessarily need or want to report the results.
Aug 23, 2023
-
Diagnostics World | Over the next three years, researchers from across five universities in Germany will be using “swarm learning” on retrospective tissue samples to gain insights on the tumor biology of hereditary colorectal cancer (CRC).
Aug 22, 2023
-
Diagnostics World | In a surprising twist, researchers at Sanford Burnham Prebys have found that both age and sex may matter a great deal when it comes to the consequences of many types of cancer.
Aug 16, 2023
-
Diagnostics World | Researchers at the University of Virginia School of Medicine have identified early biomarkers linked to preeclampsia that could help OB/GYNs better understand which of their patients are at risk of developing the potentially deadly pregnancy complication and perhaps help get at why the condition occurs in the first place.
Aug 15, 2023